FI103117B1 - Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi

Info

Publication number
FI103117B1
FI103117B1 FI920460A FI920460A FI103117B1 FI 103117 B1 FI103117 B1 FI 103117B1 FI 920460 A FI920460 A FI 920460A FI 920460 A FI920460 A FI 920460A FI 103117 B1 FI103117 B1 FI 103117B1
Authority
FI
Finland
Prior art keywords
bis
tetrazolylpyridines
preparation
therapeutically useful
hydroxylase
Prior art date
Application number
FI920460A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI920460A0 (fi
FI920460A (fi
FI103117B (fi
Inventor
Gerrit Schubert
Ekkehard Baader
Martin Bickel
Volkmar Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI920460A0 publication Critical patent/FI920460A0/fi
Publication of FI920460A publication Critical patent/FI920460A/fi
Application granted granted Critical
Publication of FI103117B publication Critical patent/FI103117B/fi
Publication of FI103117B1 publication Critical patent/FI103117B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI920460A 1991-02-05 1992-02-03 Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi FI103117B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4103372 1991-02-05
DE4103372 1991-02-05

Publications (4)

Publication Number Publication Date
FI920460A0 FI920460A0 (fi) 1992-02-03
FI920460A FI920460A (fi) 1992-08-06
FI103117B FI103117B (fi) 1999-04-30
FI103117B1 true FI103117B1 (fi) 1999-04-30

Family

ID=6424383

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920460A FI103117B1 (fi) 1991-02-05 1992-02-03 Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi

Country Status (23)

Country Link
US (2) US5482953A (sh)
EP (1) EP0498334B1 (sh)
JP (1) JPH0559041A (sh)
KR (1) KR100214797B1 (sh)
AT (1) ATE193288T1 (sh)
AU (1) AU650511B2 (sh)
CA (1) CA2060622A1 (sh)
CZ (1) CZ283006B6 (sh)
DE (1) DE59209838D1 (sh)
DK (1) DK0498334T3 (sh)
ES (1) ES2146581T3 (sh)
FI (1) FI103117B1 (sh)
GR (1) GR3033536T3 (sh)
HR (1) HRP940840B1 (sh)
HU (1) HUT61295A (sh)
IE (1) IE920368A1 (sh)
IL (1) IL100860A (sh)
MX (1) MX9200492A (sh)
NO (1) NO180446C (sh)
NZ (1) NZ241505A (sh)
PT (1) PT498334E (sh)
YU (1) YU9492A (sh)
ZA (1) ZA92788B (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ305460B6 (cs) * 2013-05-06 2015-10-07 Contipro Biotech S.R.O. Způsob přípravy esteru 2-oxoglutarátu, přípravek obsahující ester 2-oxoglutarát a jeho použití

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
US5238948A (en) * 1987-02-10 1993-08-24 Hoechst Aktiengesellschaft Pyridine-2,4- and -2,5-dicarboxylic acid derivatives and medicaments based on these compounds
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
JPH02178263A (ja) * 1988-12-27 1990-07-11 Kaken Pharmaceut Co Ltd アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
FR2655801B1 (fr) * 1989-12-08 1992-03-13 Charbonnages De France Procede et dispositif de transmission de signaux video en milieu confine.
ZA91291B (en) * 1990-01-16 1991-09-25 Hoechst Ag Di(nitroxyalkyl)amides of pyridine-2,4-and-2,5-dicarboxylic acids,a process for the preparation thereof,and the use thereof
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
KR920016443A (ko) 1992-09-24
FI920460A0 (fi) 1992-02-03
DK0498334T3 (da) 2000-09-18
CZ283006B6 (cs) 1997-12-17
GR3033536T3 (en) 2000-09-29
PT498334E (pt) 2000-09-29
KR100214797B1 (ko) 1999-08-02
US5482953A (en) 1996-01-09
IL100860A (en) 1995-11-27
DE59209838D1 (de) 2000-06-29
NZ241505A (en) 1994-12-22
NO920462L (no) 1992-08-06
JPH0559041A (ja) 1993-03-09
US5614537A (en) 1997-03-25
NO920462D0 (no) 1992-02-04
EP0498334A1 (de) 1992-08-12
NO180446C (no) 1997-04-23
FI920460A (fi) 1992-08-06
NO180446B (no) 1997-01-13
AU650511B2 (en) 1994-06-23
CA2060622A1 (en) 1992-08-06
YU9492A (sh) 1995-03-27
HUT61295A (en) 1992-12-28
IL100860A0 (en) 1992-11-15
FI103117B (fi) 1999-04-30
AU1072492A (en) 1992-08-13
HRP940840A2 (en) 1997-06-30
IE920368A1 (en) 1992-08-12
HU9200336D0 (en) 1992-04-28
EP0498334B1 (de) 2000-05-24
HRP940840B1 (en) 2000-12-31
ATE193288T1 (de) 2000-06-15
ES2146581T3 (es) 2000-08-16
ZA92788B (en) 1992-10-28
MX9200492A (es) 1992-08-01
CS30992A3 (en) 1992-11-18

Similar Documents

Publication Publication Date Title
AU588826B2 (en) Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase
NO940789L (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
ATE162800T1 (de) Inhibitoren mit zweifacher wirkung
AU657166B2 (en) Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
NO178026C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,4- og 2,5-substituerte pyridin-N-oksider
MY104354A (en) Non-peptidic renin inhibitors
FI103117B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2,4- ja 2,5-bis-tetratsolyylipyridiinien valmistamiseksi
DE3887916D1 (de) Schaltung zum automatischen Regeln des Verstärkung-Bandbreite-Produktes von Operationsverstärkern.
NO910163L (no) Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.
AU1516892A (en) Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
AP9400608A0 (en) "New nicotinic acid derivative".
DK0379288T3 (da) Fremgangsmåde og mellemprodukter for isopropyl 3S-amino-2R-hydroxyalkanoater
MX9704739A (es) Monomeros de 3,3-(disustituido)ciclohexan-1-ona y compuestos relacionados.